Top Markets
Coin of the day
3B BlackBio Dx Ltd 3B BlackBio Dx Ltd

3B BlackBio Dx Ltd

3BBLACKBIO
Rang in Aktien #21276
Established in 1972 and headquartered in Bhopal, India, 3B Blackbio Dx Limited... Established in 1972 and headquartered in Bhopal, India, 3B Blackbio Dx Limited specializes in the conception, production, and market distribution of sophisticated molecular diagnostic technologies. The company's core focus is on delivering solutions for pressing health concerns such as infectious diseases, oncology, human genetics, and the challenge of antimicrobial resistance, primarily serving the Indian market. Their comprehensive product portfolio includes qPCR-based assays, swift lateral flow rapid tests, and cutting-edge Next Generation Sequencing (NGS) molecular diagnostic kits. These offerings are designed to enable precise and dependable analysis of patient samples by diagnostic laboratories, marketed under reputable brands like TRUPCR, TRUNGS, and TRURAPID. Beyond diagnostics, 3B Blackbio Dx Limited also supplies agrochemical products and provides essential technical support and training services.
Aktienkurs
$12.94
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$111.10M
Veränderung (1 Tag)
3.03%
Veränderung (1 Jahr)
-21.30%
Land
IN
Handel 3B BlackBio Dx Ltd (3BBLACKBIO)

Kategorie

EPS für 3B BlackBio Dx Ltd (3BBLACKBIO)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von 3B BlackBio Dx Ltd beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von 3B BlackBio Dx Ltd von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH